Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

July’s top stories: Immunocore, Genentech to develop ImmTACs

Immunocore and Genentech have formed a strategic alliance to develop ImmTACs against multiple cancers, while ARTES Biotechnology and Bio Farma have collaborated to develop and manufacture vaccine candidates. Drugdevelopment-technology.com wraps up key headlines from July 2013.

Go Top